Min Hou
Nanchong, 637000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Osteopontin Promotes Lung Cancer Growth through NF-κB-Dependent Upregulation of PD-L1 and Suppression of Anti-Tumor Immunity.
Journal: Molecular biology reports
Published: March 07, 2026
The FGD5-AS1/miR-142-5p/CDK5 axis promotes ESCC progression by regulating mitochondrial fission and mitophagy: insights from integrative bioinformatics and experimental analyses.
Journal: World journal of surgical oncology
Published: December 11, 2025
Radiotherapy dose may not affect prognosis in ESCC patients receiving first-line chemoradiotherapy-immunotherapy: A multicenter retrospective study.
Journal: Cancer immunology, immunotherapy : CII
Published: September 18, 2025
Impact of first-line chemoimmunotherapy with or without radiotherapy on the prognosis of patients with locally advanced or metastatic esophageal squamous cell carcinoma: a multicenter, real-world, retrospective cohort study from China (NCT06478355).
Journal: Frontiers in immunology
Published: May 23, 2025
RNA binding protein RBM22 suppresses non-small cell lung cancer tumorigenesis by stabilizing LATS1 mRNA.
Journal: Journal of molecular histology
Published: May 09, 2024
The zinc figure protein ZNF575 impairs colorectal cancer growth via promoting p53 transcription.
Journal: Oncology research
Published: December 25, 2022
Linalool Impress Colorectal Cancer Deterioration by Mediating AKT/mTOR and JAK2/STAT3 Signaling Pathways.
Journal: BioMed research international
Published: May 18, 2022
Nomogram Integrating Genomics with Clinicopathologic Features Improves Prognosis Prediction for Colorectal Cancer.
Journal: Molecular cancer research : MCR
Published: January 19, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026